Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce R Bacon

Showing results (91-100 of 118) with videos related to

Pageof 12
Sort By:
The New England Journal of Medicine|July 13, 2007
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3Mitchell L Shiffman, Fredy Suter, Bruce R Bacon, et al.
The American Journal of Gastroenterology|June 18, 2003
Insurance, employment, and psychosocial consequences of a diagnosis of hereditary hemochromatosis in subjects without end organ damageNicholas J Shaheen, Laura B Lawrence, Bruce R Bacon, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 30, 2002
Hepatic iron concentration does not influence response to therapy with interferon plus ribavirin in chronic HCV infectionStephen Pianko, John G McHutchison, Stuart C Gordon, et al.
American Journal of Nephrology|February 14, 2018
Positive Iron Balance in Chronic Kidney Disease: How Much is Too Much and How to Tell?Jay B Wish, George R Aronoff, Bruce R Bacon, et al.
Hepatology (Baltimore, Md.)|January 15, 2013
A global view of hepatitis C: physician knowledge, opinions, and perceived barriers to careChristopher E McGowan, Ali Monis, Bruce R Bacon, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 16, 2003
Contribution of the H63D mutation in HFE to murine hereditary hemochromatosisShunji Tomatsu, Koji O Orii, Robert E Fleming, et al.
The American Journal of Gastroenterology|October 3, 2002
Use of complementary and alternative medicine in patients with liver diseaseDoris B Strader, Bruce R Bacon, Karen L Lindsay, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 22, 2014
Accuracy of fibroscan, compared with histology, in analysis of liver fibrosis in patients with hepatitis B or C: a United States multicenter studyNezam H Afdhal, Bruce R Bacon, Keyur Patel, et al.
Gastroenterology|April 27, 2017
Hepatitis C Virus Infection Care Pathway-A Report From the American Gastroenterological Association Institute HCV Care Pathway Work GroupFasiha Kanwal, Bruce R Bacon, Lauren A Beste, et al.
Hepatology (Baltimore, Md.)|August 18, 2016
Evaluation of proton pump inhibitor use on treatment outcomes with ledipasvir and sofosbuvir in a real-world cohort studyElliot B Tapper, Bruce R Bacon, Michael P Curry, et al.
Pageof 12

Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
The New England Journal of Medicine|July 13, 2007
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3Mitchell L Shiffman, Fredy Suter, Bruce R Bacon, et al.
The American Journal of Gastroenterology|June 18, 2003
Insurance, employment, and psychosocial consequences of a diagnosis of hereditary hemochromatosis in subjects without end organ damageNicholas J Shaheen, Laura B Lawrence, Bruce R Bacon, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 30, 2002
Hepatic iron concentration does not influence response to therapy with interferon plus ribavirin in chronic HCV infectionStephen Pianko, John G McHutchison, Stuart C Gordon, et al.
American Journal of Nephrology|February 14, 2018
Positive Iron Balance in Chronic Kidney Disease: How Much is Too Much and How to Tell?Jay B Wish, George R Aronoff, Bruce R Bacon, et al.
Hepatology (Baltimore, Md.)|January 15, 2013
A global view of hepatitis C: physician knowledge, opinions, and perceived barriers to careChristopher E McGowan, Ali Monis, Bruce R Bacon, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 16, 2003
Contribution of the H63D mutation in HFE to murine hereditary hemochromatosisShunji Tomatsu, Koji O Orii, Robert E Fleming, et al.
The American Journal of Gastroenterology|October 3, 2002
Use of complementary and alternative medicine in patients with liver diseaseDoris B Strader, Bruce R Bacon, Karen L Lindsay, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 22, 2014
Accuracy of fibroscan, compared with histology, in analysis of liver fibrosis in patients with hepatitis B or C: a United States multicenter studyNezam H Afdhal, Bruce R Bacon, Keyur Patel, et al.
Gastroenterology|April 27, 2017
Hepatitis C Virus Infection Care Pathway-A Report From the American Gastroenterological Association Institute HCV Care Pathway Work GroupFasiha Kanwal, Bruce R Bacon, Lauren A Beste, et al.
Hepatology (Baltimore, Md.)|August 18, 2016
Evaluation of proton pump inhibitor use on treatment outcomes with ledipasvir and sofosbuvir in a real-world cohort studyElliot B Tapper, Bruce R Bacon, Michael P Curry, et al.
Pageof 12